Evidence-Based Medicine Guidelines
Tumor necrosis factor-alpha antibody for maintenace of remission in Crohn's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tumor Necrosis Factor-alpha Antibody for Maintenace of Remission in Crohn's Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456566/all/Tumor_necrosis_factor_alpha_antibody_for_maintenace_of_remission_in_Crohn's_disease.
Tumor necrosis factor-alpha antibody for maintenace of remission in Crohn's disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456566/all/Tumor_necrosis_factor_alpha_antibody_for_maintenace_of_remission_in_Crohn's_disease. Accessed December 10, 2023.
Tumor necrosis factor-alpha antibody for maintenace of remission in Crohn's disease. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456566/all/Tumor_necrosis_factor_alpha_antibody_for_maintenace_of_remission_in_Crohn's_disease
Tumor Necrosis Factor-alpha Antibody for Maintenace of Remission in Crohn's Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 December 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456566/all/Tumor_necrosis_factor_alpha_antibody_for_maintenace_of_remission_in_Crohn's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tumor necrosis factor-alpha antibody for maintenace of remission in Crohn's disease
ID - 456566
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456566/all/Tumor_necrosis_factor_alpha_antibody_for_maintenace_of_remission_in_Crohn's_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
